MECLIZINE HYDROCHLORIDE (meclizine hydrochloride) by Molecular Devices is 12. Approved for vertigo associated with diseases affecting the vestibular system in adults ( ). First approved in 2022.
Drug data last refreshed 23h ago
12.1 Mechanism of Action The precise mechanism by which meclizine exerts its therapeutic effect is unknown but is presumed to involve antagonism of the histamine H1 receptor. 12.2 Pharmacodynamics There are no relevant pharmacodynamic data regarding meclizine. 12.3 Pharmacokinetics The available…
Worked on MECLIZINE HYDROCHLORIDE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.